Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Maynard

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Annals of Occupational Hygiene|January 26, 2005
Laboratory and field evaluation of a new personal sampling system for assessing the protection provided by the N95 filtering facepiece respirators against particlesShu-An Lee, Sergey A Grinshpun, Atin Adhikari, et al.
Journal of Toxicology and Environmental Health. Part A|September 30, 2003
Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cellsAnna A Shvedova, Vincent Castranova, Elena R Kisin, et al.
Environmental Health Perspectives|August 3, 2006
Translocation of inhaled ultrafine manganese oxide particles to the central nervous systemAlison Elder, Robert Gelein, Vanessa Silva, et al.
Journal of Occupational and Environmental Hygiene|October 26, 2011
A strategy for assessing workplace exposures to nanomaterialsGurumurthy Ramachandran, Michele Ostraat, Douglas E Evans, et al.
Nature Nanotechnology|July 26, 2008
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot studyCraig A Poland, Rodger Duffin, Ian Kinloch, et al.
Journal of Medicinal Chemistry|February 27, 2014
Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compoundWieslaw M Kazmierski, Andrew Maynard, Maosheng Duan, et al.
Particle and Fibre Toxicology|October 8, 2005
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyGünter Oberdörster, Andrew Maynard, Ken Donaldson, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2005
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in miceAnna A Shvedova, Elena R Kisin, Robert Mercer, et al.
Journal of Medicinal Chemistry|May 16, 2013
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymeraseAndrew Maynard, Renae M Crosby, Byron Ellis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Annals of Occupational Hygiene|January 26, 2005
Laboratory and field evaluation of a new personal sampling system for assessing the protection provided by the N95 filtering facepiece respirators against particlesShu-An Lee, Sergey A Grinshpun, Atin Adhikari, et al.
Journal of Toxicology and Environmental Health. Part A|September 30, 2003
Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cellsAnna A Shvedova, Vincent Castranova, Elena R Kisin, et al.
Environmental Health Perspectives|August 3, 2006
Translocation of inhaled ultrafine manganese oxide particles to the central nervous systemAlison Elder, Robert Gelein, Vanessa Silva, et al.
Journal of Occupational and Environmental Hygiene|October 26, 2011
A strategy for assessing workplace exposures to nanomaterialsGurumurthy Ramachandran, Michele Ostraat, Douglas E Evans, et al.
Nature Nanotechnology|July 26, 2008
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot studyCraig A Poland, Rodger Duffin, Ian Kinloch, et al.
Journal of Medicinal Chemistry|February 27, 2014
Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compoundWieslaw M Kazmierski, Andrew Maynard, Maosheng Duan, et al.
Particle and Fibre Toxicology|October 8, 2005
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyGünter Oberdörster, Andrew Maynard, Ken Donaldson, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2005
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in miceAnna A Shvedova, Elena R Kisin, Robert Mercer, et al.
Journal of Medicinal Chemistry|May 16, 2013
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymeraseAndrew Maynard, Renae M Crosby, Byron Ellis, et al.
Pageof 3